Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease.

Dopheide, Jörn F; Veit, Jonas; Ramadani, Hana; Adam, Luise; Papac, Lucija; Vonbank, Alexander; Kaspar, Mathias; Rastan, Aljoscha; Baumgartner, Iris; Drexel, Heinz (2021). Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. European heart journal - cardiovascular pharmacotherapy, 7(4), pp. 263-270. Oxford University Press 10.1093/ehjcvp/pvz081

Text Dopheide, Eur Heart J Cardiovasc Pharmacother 2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (454kB)

AIMS

We hypothesized that adherence to statin therapy determines survival in patients with peripheral artery disease (PAD).

METHODS AND RESULTS

Single-centre longitudinal observational study with 691 symptomatic PAD patients. Mortality was evaluated over a mean follow-up of 50 ± 26 months. We related statin adherence and low-density lipoprotein cholesterol (LDL-C) target attainment to all-cause mortality. Initially, 73% of our PAD patients were on statins. At follow-up, we observed an increase to 81% (P < 0.0001). Statin dosage, normalized to simvastatin 40 mg, increased from 50 to 58 mg/day (P < 0.0001), and was paralleled by a mean decrease of LDL-C from 97 to 82 mg/dL (P < 0.0001). The proportion of patients receiving a high-intensity statin increased over time from 38% to 62% (P < 0.0001). Patients never receiving statins had a significant higher mortality rate (31%) than patients continuously on statins (13%) or having newly received a statin (8%; P < 0.0001). Moreover, patients on intensified statin medication had a low mortality of 9%. Those who terminated statin medication or reduced statin dosage had a higher mortality (34% and 20%, respectively; P < 0.0001). Multivariate analysis showed that adherence to or an increase of the statin dosage (both P = 0.001), as well as a newly prescribed statin therapy (P = 0.004) independently predicted reduced mortality.

CONCLUSION

Our data suggest that adherence to statin therapy is associated with reduced mortality in symptomatic PAD patients. A strategy of intensive and sustained statin therapy is recommended.

Interest & Impact

Downloads

2 since deposited on 07 Jan 2020
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item